Shorr AF - Search Results

1

Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated).

Shorr AF, Janes JM, Artigas A, Tenhunen J, Wyncoll DL, Mercier E, Francois B, Vincent JL, Vangerow B, Heiselman D, Leishman AG, Zhu YE, Reinhart K; RESPOND investigators. Shorr AF, et al. Crit Care. 2010;14(6):R229. doi: 10.1186/cc9382. Epub 2010 Dec 21. Crit Care. 2010. PMID: 21176144 Free PMC article. Clinical Trial.

2

Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure.

Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dhainaut JF, et al. Among authors: shorr af. Crit Care Med. 2005 Feb;33(2):341-8. doi: 10.1097/01.ccm.0000153520.31562.48. Crit Care Med. 2005. PMID: 15699837

3

Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.

Shorr AF, Zadeikis N, Jackson WL, Ramage AS, Wu SC, Tennenberg AM, Kollef MH. Shorr AF, et al. Clin Infect Dis. 2005 Feb 15;40 Suppl 2:S123-9. doi: 10.1086/426192. Clin Infect Dis. 2005. PMID: 15712100 Clinical Trial.

4

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.

Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH. Shorr AF, et al. Crit Care Med. 2005 Sep;33(9):1928-35; quiz 1936. doi: 10.1097/01.ccm.0000178352.14703.49. Crit Care Med. 2005. PMID: 16148461

5

A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia.

Shorr AF, Zadeikis N, Xiang JX, Tennenberg AM, Wes Ely E. Shorr AF, et al. Clin Ther. 2005 Aug;27(8):1251-9. doi: 10.1016/s0149-2918(05)80214-0. Clin Ther. 2005. PMID: 16199249 Clinical Trial.

6

Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.

Shorr AF, Khashab MM, Xiang JX, Tennenberg AM, Kahn JB. Shorr AF, et al. Respir Med. 2006 Dec;100(12):2129-36. doi: 10.1016/j.rmed.2006.03.019. Epub 2006 May 26. Respir Med. 2006. PMID: 16730170 Free article. Clinical Trial.

7

Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome.

Shorr AF, Bernard GR, Dhainaut JF, Russell JR, Macias WL, Nelson DR, Sundin DP. Shorr AF, et al. Crit Care. 2006;10(3):R92. doi: 10.1186/cc4946. Epub 2006 Jun 15. Crit Care. 2006. PMID: 16780598 Free PMC article. Clinical Trial.

8

Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?

Shorr AF, Micek ST, Jackson WL Jr, Kollef MH. Shorr AF, et al. Crit Care Med. 2007 May;35(5):1257-62. doi: 10.1097/01.CCM.0000261886.65063.CC. Crit Care Med. 2007. PMID: 17414080

9

The protein C pathway: implications for the design of the RESPOND study.

Vangerow B, Shorr AF, Wyncoll D, Janes J, Nelson DR, Reinhart K. Vangerow B, et al. Among authors: shorr af. Crit Care. 2007;11 Suppl 5(Suppl 5):S4. doi: 10.1186/cc6155. Crit Care. 2007. PMID: 18269691 Free PMC article. Review.

10

Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial.

Shorr AF, Cook D, Jiang X, Muscedere J, Heyland D; Canadian Critical Care Trials Group. Shorr AF, et al. J Crit Care. 2008 Mar;23(1):64-73. doi: 10.1016/j.jcrc.2007.11.010. J Crit Care. 2008. PMID: 18359423 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters